| Schedule of Earnings Per Share |
The following table sets forth the computation
of the Company’s basic and diluted net loss per share during the three months ended March 31, 2020 and 2019:
| |
|
Three Months Ended March 31, |
|
| |
|
2020 |
|
|
2019 |
|
| Numerator |
|
|
|
|
|
|
| Net loss from continuing operations |
|
$ |
(5,752,003 |
) |
|
$ |
(12,932,795 |
) |
| Deemed dividends from trigger of down round provision feature |
|
|
- |
|
|
|
(123,861,587 |
) |
| Net loss attributable to common stockholders, continuing operations |
|
$ |
(5,752,003 |
) |
|
$ |
(136,794,382 |
) |
| Net loss from discontinued operations |
|
|
(39,775 |
) |
|
|
(508,609 |
) |
| Net loss available to common stockholders |
|
$ |
(5,791,778 |
) |
|
$ |
(137,302,991 |
) |
| |
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
| Basic and diluted weighted average common shares outstanding |
|
|
9,813,222,489 |
|
|
|
1,404,610,862 |
|
| |
|
|
|
|
|
|
|
|
| Loss per share, basic and diluted |
|
|
|
|
|
|
|
|
| Basic and diluted, continuing operations |
|
$ |
(0.00 |
) |
|
$ |
(0.10 |
) |
| Basic and diluted, discontinued operations |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
| Total basic and diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.10 |
) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
As of March 31, 2020 and 2019, the following
potential common stock equivalents were excluded from the calculation of diluted loss per share as their effect was anti-dilutive:
| |
|
Three Months Ended March 31, |
|
| |
|
2020 |
|
|
2019 |
|
| Warrants |
|
|
634,585,355,375 |
|
|
|
634,585,355,377 |
|
| Convertible preferred stock |
|
|
78,872,373,825 |
|
|
|
87,902,722,060 |
|
| Convertible debentures |
|
|
30,634,784,339 |
|
|
|
30,570,395,193 |
|
| Stock options |
|
|
68 |
|
|
|
77 |
|
| |
|
|
744,092,513,607 |
|
|
|
753,058,472,707 |
|
|